BRAF and metastatic malignant neoplasm in the lymph nodes: In contrast, there were no significant associations between GREB1 and MITF expression and age, sex, lymph node metastasis, melanoma subtypes, BRAF mutations, or stages (Supplementary Fig. S5A and Table 1).